维普期刊资源整合服务平台（V6.5）

49篇 您的检索式：作者名="Reaven PD"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Molecular and signaling mechanisms of atherosclerosis in insulin resistance显示文摘	Schwartz EA Reaven PD	2006	Endocrinol Metab Clin North Am2006，35，3：	1
2	Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis显示文摘	Reaven PD Moritz TE Schwenke DC	2009	Diabetes2009，58，11：	1
3	Molecular and signaling mechanisms of atheroselemsis in insulin resistance显示文摘	Schwartz EA Reaven PD	2006	EndocrinoMetab Clin North Am2006，27，3：	1
4	Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis显示文摘	Reaven PD Moritz TE Schwenke DC	2009	Diabetes2009，58，11：	1
5	Intensive glu- cose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower cal- cified coronary atherosclerosis 显示文摘	Reaven PD Moritz TE Schwenke DC	2009	Diabetes2009，58，11：	1
6	Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes显示文摘	Hayward RA Reaven PD Wiitala WL	2015	N Engl J Med2015，372，23：	1
7	Postprandial hyperlipidemia,endothelial dysfunction and cardiovascular risk:focus on incretins显示文摘	Ansar S Koska J Reaven PD	2011	Cardiovasc Diabetol2011，10，1：	1
8	Effects of Vitamin E onsusceptibility of low-density lipoprotein and low-density lipoproteinsubfractions to oxidation and on protein glycation in NIDDM显示文摘	Reaven PD Herold DA Barnett J	1995	Diabetes Care1995，18，6：	1
9	Intensive glu- cose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis显示文摘	Reaven PD Moritz TE Schwenke DC	2009	Diabetes2009，58，：	1
10	Molecular and signaling mechanisms of atherosclerosis in insulin resistance显示文摘	Schwartz EA Reaven PD	2006	Endoerinol Metab Clin North Am2006，27，3：	1
11	Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk : focus on incretins 显示文摘	Ansar S Koska J Reaven PD	2011	Cardiovasc Diabetol2011，10，1：	1
12	Cardiovascular disease in diabetes mellitus type 2 : a potential role of novel cardiovascular risk factors 显示文摘	Hayden JM Reaven PD	2000	Curr Opin Lipidol2000，11，5：	1
13	Peroxisome proliferatoractivated receptor-alpha and atherosclerosis:from basic mechanisms to clinical implications显示文摘	Israelian-Konaraki Z Reaven PD	2005	Cardiology2005，103，1：	1
14	Exercise training is not associated with improved levels of C - reactive protein or adiponeetin 显示文摘	Marcell TJ MeAuley KA Traustadottir T Reaven PD	2005	Metabolism2005，54，4：	1
15	Proliferative diabetic retinopathy in type 2 diabetes is related to coronary artery calcium in the veterans affairs diabetes trial(VADT)显示文摘	Reaven PD Emanuele N Moritz T	2008	Diabetes Care2008，31，5：	1
16	Coronary artery and abdominal aortic calcification are associated with cardiovascular disease in type 2 diabetes显示文摘	PD Reaven J Sacks		0，，：	1
17	Susceptibility of human LDL to oxidative modifications: effects of variations in betacarotene concentration and oxygen tension 显示文摘	Reaven PD Ferguson E Navab M	1994	Arterioscler Thromb Vasc Biol1994，14，：	1
18	Effect of probucol dosage on plasma lipid and lipoprotein levels and on protection no flow density lipoprotein against in vitro oxidation in humans显示文摘	Reaven PD Parthasarathy S Beltz WE	1992	Arterioscler Thromb1992，12，3：	1
19	Reduced coronary artery and abdominal aortic calcification in Hispanics with type 2 diabetes, investigators for the velerans affairs cooperative study of glycemie control and complications in diabetes meUitus type 2 显示文摘	Reaven PD Sacks J	2004	Diabetes Care2004，27，5：	1
20	Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk:focus on incretins 显示文摘	Ansar S Koska J Reaven PD		Cardiovasc Diabeto10，10，1：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示